Skip to main content

Closed

PTGX: Protagonist Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-192.4%

ROIC-21.3%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio17.76×

Protagonist Therapeutics, Inc.

PTGXNASDAQ Global Market·USD·Closed

Protagonist Therapeutics, Inc.

PTGXNASDAQ·USD·Closed

$136.64

−1.44%

$136.64

−$2.00 (1.44%)

52W Range

93thpctl

Volume

0.77×avg

Mkt Cap

8.79BUSD

P/E

-75.8TTM

Div Yield

–ann

52W Range

93thpctl

Volume

0.77×avg

Market Cap

8.79BUSD

P/E Ratio

-75.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings